Mar 2, 2023 4:00 pm EST Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023
Jan 9, 2023 7:00 am EST Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
Jan 5, 2023 7:00 am EST Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits
Dec 19, 2022 7:00 am EST Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation
Oct 31, 2022 7:00 am EDT Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D.
Oct 20, 2022 7:00 am EDT Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022
